Amgen Financials

Market Capitalization $159.62 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	27.04
Forward PE	14.36
Price to Sales TTM	$4.68
Price to Book MRQ	$25.71
Enterprise to Revenue	5.82
Enterprise to EBITDA	12.64

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	17.39%
Operating Margin	28.73%
Return on Assets TTM	7.04%
Return on Equity TTM	105.67%

Income Statement

Revenue TTM	$34,126,000,128
Revenue per Share TTM	$63.49
Quarterly Revenue Growth	9.40%
Gross Profit TTM	$23,569,999,872
EBITDA	$15,284,000,000
Net Income to Common TTM	$5,933,000,192
Diluted EPS TTM	$10.98
Quarterly Earnings Growth YoY	9.43%

Balance Sheet

Total Cash MRQ	$8,810,000,384
Total Cash per Share MRQ	$16.38
Total Debt MRQ	$
Total Debt to Equity MRQ	924.46
Current Ratio MRQ	1.17
Book Value per Share MRQ	$11.54

Cash Flow

Operating Cash Flow TTM	$12,192,000,000
Levered Free Cash Flow TTM	$13,090,124,800

AMGN Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	537,000,000
Float Shares	536,334,967
Avg 10 Volume	3,565,110
Avg 30 Volume	None
Shares Short	13,271,690
Short Ratio	4.94
Short % of Shares	2.48%
% Held by Insiders	0.21%
% Held by Institutions	83.59%

Stock Price Summary

Beta	0.50
Fifty Two Week Low	$253.30
Fifty Two Week High	$346.85
Fifty Two Week Change	-4.24%
Day 50 MA	$281.21
Day 200 MA	$294.21

Dividends and Splits

Forward Annual Dividend Rate	$9.52
Forward Annual Dividend Yield	3.19%
Trailing Annual Dividend Rate	$9.26
Trailing Annual Dividend Yield	3.10%
Payout Ratio	83.23%
Dividend Date	2025-06-06
Ex Dividend Date	2025-05-16
Last Split Factor
Last Split Date	1999-11-22